Suling Sun
Science Island Branch
Hefei, China
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Karyopherin Subunit Alpha 3 Drives Temozolomide Resistance in Glioblastoma by Upregulating MGMT and Activating STAT3 to Sustain Glioma Stem Cells.
Journal: Cell biology international
Published: February 04, 2026
Development of stemness-related signature to optimize prognosis prediction and identify XMD8-85 as a novel therapeutic compound for glioma.
Journal: Cellular signalling
Published: March 10, 2024
Copper Homeostasis Based on Cuproptosis-Related Signature Optimizes Molecular Subtyping and Treatment of Glioma.
Journal: Molecular neurobiology
Published: November 03, 2023
Chinese herb related molecules Catechins, Caudatin and Cucurbitacin-I inhibit the proliferation of glioblastoma by activating KDELR2-mediated endoplasmic reticulum stress.
Journal: Biochemical and biophysical research communications
Published: October 25, 2023
GFAP palmitoylcation mediated by ZDHHC23 in spinal astrocytes contributes to the development of neuropathic pain.
Journal: Regional anesthesia and pain medicine
Published: September 03, 2023
Blocking Palmitoylation of Apelin Receptor Alleviates Morphine Tolerance in Neuropathic Cancer Pain.
Blocking Palmitoylation of Apelin Receptor Alleviates Morphine Tolerance in Neuropathic Cancer Pain.
Journal: International journal of biological sciences
Published: June 07, 2023
Loss of p53 Concurrent with RAS and TERT Activation Induces Glioma Formation.
Journal: Molecular neurobiology
Published: November 10, 2022
In reply to Tang et al.
Journal: International journal of radiation oncology, biology, physics
Published: May 19, 2022
Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma.
Journal: BMC cancer
Published: April 29, 2022
GSK3β palmitoylation mediated by ZDHHC4 promotes tumorigenicity of glioblastoma stem cells in temozolomide-resistant glioblastoma through the EZH2-STAT3 axis.
Journal: Oncogenesis
Published: February 08, 2022
Last Updated: 09/26/2026